@ajakola.bsky.social
Reposted
#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration!
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
October 19, 2025 at 11:00 AM
#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration!
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours.
#EANO #btsm
Wow! Great evidence now for patients with fatigue following brain tumor diagnosis. CBT helps. And effects last! Implement already? #EANO2025
October 17, 2025 at 8:37 AM
Wow! Great evidence now for patients with fatigue following brain tumor diagnosis. CBT helps. And effects last! Implement already? #EANO2025
Extremely important topic in north hall just now. Long term effects of having a brain tumor. Completely packed room, highly interesting #EANO2025
October 17, 2025 at 7:38 AM
Extremely important topic in north hall just now. Long term effects of having a brain tumor. Completely packed room, highly interesting #EANO2025
Surgical sessions kicking off today at #EANO2025. Cognitive profiles relevant to brain tumor surgery and clever techniques to circumvent the blood brain barrier for brain tumor treatment will be presented after lunch. See you there!
October 16, 2025 at 9:59 AM
Surgical sessions kicking off today at #EANO2025. Cognitive profiles relevant to brain tumor surgery and clever techniques to circumvent the blood brain barrier for brain tumor treatment will be presented after lunch. See you there!
Reposted
👉 We are very proud to present our #EANO2025 ambassadors! Follow them on LinkedIn a/o Bluesky for a range of expert insights & join the conversation using the official hashtag #EANO2025.
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
October 15, 2025 at 12:24 PM
👉 We are very proud to present our #EANO2025 ambassadors! Follow them on LinkedIn a/o Bluesky for a range of expert insights & join the conversation using the official hashtag #EANO2025.
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
We look forward to meeting you all in #Prague!
#NeuroOncology #btsm
Have you checked out the #EANO2025 programme yet? 🤓 Which neurosurgical talks do you find most interesting? 👨🏾⚕️ Happy to get suggestions and I will post my thoughts during the congress on surgical and general neuro-oncology topics ✏️🧠
October 12, 2025 at 2:16 PM
Have you checked out the #EANO2025 programme yet? 🤓 Which neurosurgical talks do you find most interesting? 👨🏾⚕️ Happy to get suggestions and I will post my thoughts during the congress on surgical and general neuro-oncology topics ✏️🧠
Reposted
A recent publication in Journal of Clinical Oncology covers stereotactic radiosurgery in small cell lung cancer patients with 1–10 brain metastases, from a multi-institutional phase II prospective trial.
🔗 ascopubs.org/doi/10.1200/...
#NeuroOncology #Glioma #BrainMetastases #EANOessentials #medsky
🔗 ascopubs.org/doi/10.1200/...
#NeuroOncology #Glioma #BrainMetastases #EANOessentials #medsky
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial
PURPOSEStereotactic radiation (SRS/SRT) as opposed to whole-brain radiation (WBRT) represents
the standard of care for patients with a limited number of brain metastases given
the relatively favorable...
ascopubs.org
July 21, 2025 at 11:10 AM
A recent publication in Journal of Clinical Oncology covers stereotactic radiosurgery in small cell lung cancer patients with 1–10 brain metastases, from a multi-institutional phase II prospective trial.
🔗 ascopubs.org/doi/10.1200/...
#NeuroOncology #Glioma #BrainMetastases #EANOessentials #medsky
🔗 ascopubs.org/doi/10.1200/...
#NeuroOncology #Glioma #BrainMetastases #EANOessentials #medsky
A timely review from Dima Harba et al. on IDH-mut gliomas.
🧬 mIDH inhibitors show promise, esp. in delaying progression.
⚛️ Proton therapy offers theoretical advantages.
Limited evidence on survival, cognition, or QoL. This needs to be addressed.
🔗 doi.org/10.1007/s007...
#glioma #braincancer
🧬 mIDH inhibitors show promise, esp. in delaying progression.
⚛️ Proton therapy offers theoretical advantages.
Limited evidence on survival, cognition, or QoL. This needs to be addressed.
🔗 doi.org/10.1007/s007...
#glioma #braincancer
A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points - Acta Neurochirurgica
Background Proton radiation therapy (PRT) and mutant isocitrate dehydrogenase inhibitors (mIDH-inhibitors) are emerging therapies for mIDH lower grade gliomas (LGGs). Despite their substantial theoret...
doi.org
July 22, 2025 at 5:32 AM
A timely review from Dima Harba et al. on IDH-mut gliomas.
🧬 mIDH inhibitors show promise, esp. in delaying progression.
⚛️ Proton therapy offers theoretical advantages.
Limited evidence on survival, cognition, or QoL. This needs to be addressed.
🔗 doi.org/10.1007/s007...
#glioma #braincancer
🧬 mIDH inhibitors show promise, esp. in delaying progression.
⚛️ Proton therapy offers theoretical advantages.
Limited evidence on survival, cognition, or QoL. This needs to be addressed.
🔗 doi.org/10.1007/s007...
#glioma #braincancer
Reposted
🎗️Today is #GlioblastomaAwarenessDay2025, designed to raise awareness of #glioblastoma, the most common primary brain cancer. At #EANO, we are dedicated to advancing scientific research, improving diagnostic tools, & developing therapies to combat this challenging disease. #GBMDay
👉 @braintumor.org
👉 @braintumor.org
July 16, 2025 at 7:28 AM
🎗️Today is #GlioblastomaAwarenessDay2025, designed to raise awareness of #glioblastoma, the most common primary brain cancer. At #EANO, we are dedicated to advancing scientific research, improving diagnostic tools, & developing therapies to combat this challenging disease. #GBMDay
👉 @braintumor.org
👉 @braintumor.org
🚨 One week left!
Submit your Late Breaking Abstract for #EANO2025 by June 25!
Share your latest high-impact data in neuro-oncology 🧠✨
Submit here
👉https://eano.eu/eano2025/abstracts/
#NeuroOncology @eanoassociation.bsky.social
Submit your Late Breaking Abstract for #EANO2025 by June 25!
Share your latest high-impact data in neuro-oncology 🧠✨
Submit here
👉https://eano.eu/eano2025/abstracts/
#NeuroOncology @eanoassociation.bsky.social
June 18, 2025 at 1:19 PM
🚨 One week left!
Submit your Late Breaking Abstract for #EANO2025 by June 25!
Share your latest high-impact data in neuro-oncology 🧠✨
Submit here
👉https://eano.eu/eano2025/abstracts/
#NeuroOncology @eanoassociation.bsky.social
Submit your Late Breaking Abstract for #EANO2025 by June 25!
Share your latest high-impact data in neuro-oncology 🧠✨
Submit here
👉https://eano.eu/eano2025/abstracts/
#NeuroOncology @eanoassociation.bsky.social
Reposted
🚨 Late Breaking Abstract Submission is now open! Be part of the #EANO2025 scientific programme – submit your abstract by June 25, 2025 and share your latest findings with the #NeuroOncology community.
👉 eano.eu/eano2025/abs...
#NeuroSurgery #CancerNurse #BrainTumor #btsm
👉 eano.eu/eano2025/abs...
#NeuroSurgery #CancerNurse #BrainTumor #btsm
June 11, 2025 at 8:15 PM
🚨 Late Breaking Abstract Submission is now open! Be part of the #EANO2025 scientific programme – submit your abstract by June 25, 2025 and share your latest findings with the #NeuroOncology community.
👉 eano.eu/eano2025/abs...
#NeuroSurgery #CancerNurse #BrainTumor #btsm
👉 eano.eu/eano2025/abs...
#NeuroSurgery #CancerNurse #BrainTumor #btsm